IG
ACAD icon

ING Group’s Acadia Pharmaceuticals ACAD Stock Holding History

ING Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-456,177
Closed -$6.97M – 763
2018
Q2 		$6.97M Buy
+456,177
New +$8.13M 0.13% 95
2017
Q2 		– Sell
-11,300
Closed -$388K – 826
2017
Q1 		$388K Sell
11,300
-19,665
-64% -$694K 0.01% 474
2016
Q4 		$891K Sell
30,965
-4,000
-11% -$106K 0.02% 333
2016
Q3 		$1.14M Buy
+34,965
New +$1.19M 0.01% 274
2013
Q4 		– Sell
-41,000
Closed -$1.13M – 687
2013
Q3 		$1.13M Buy
+41,000
New +$857K 0.01% 548

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return